Benzinga - by Benzinga Insights, Benzinga Staff Writer.
Disclosed on May 14, BARBARA DESOER, Director at DaVita (NYSE:DVA), executed a substantial insider sell as per the latest SEC filing.
What Happened: According to a Form 4 filing with the U.S. Securities and Exchange Commission on Tuesday, DESOER sold 5,030 shares of DaVita. The total transaction value is $698,214.
DaVita's shares are actively trading at $136.34, experiencing a down of 0.49% during Wednesday's morning session.
All You Need to Know About DaVita DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Unraveling the Financial Story of DaVita Revenue Growth: Over the 3 months period, DaVita showcased positive performance, achieving a revenue growth rate of 6.89% as of 31 March, 2024. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company excelled with a growth rate higher than the average among peers.
Holistic Profitability Examination:
- Gross Margin: The company sets a benchmark with a high gross margin of 32.29%, reflecting superior cost management and profitability compared to its peers.
- Earnings per Share (EPS): The company excels with an EPS that surpasses the industry average. With a current EPS of 2.73, DaVita showcases strong earnings per share.
Exploring Valuation Metrics Landscape:
- Price to Earnings (P/E) Ratio: DaVita's P/E ratio of 15.53 is below the industry average, suggesting the stock may be undervalued.
- Price to Sales (P/S) Ratio: With a lower-than-average P/S ratio of 1.03, the stock presents an attractive valuation, potentially signaling a buying opportunity for investors interested in sales performance.
- EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation & Amortization): DaVita's EV/EBITDA ratio, lower than industry averages at 9.45, indicates attractively priced shares.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
Navigating the Impact of Insider Transactions on Investments Insightful as they may be, insider transactions should be considered alongside a thorough examination of other investment criteria.
In the context of legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as outlined by Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are obligated to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
Pointing towards optimism, a company insider's new purchase signals their positive anticipation for the stock to rise.
Despite insider sells not always signaling a bearish sentiment, they can be driven by various factors.
A Closer Look at Important Transaction Codes Navigating through the landscape of transactions, investors often prioritize those unfolding in the open market, precisely detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
Check Out The Full List Of DaVita's Insider Trades.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.